Best Practice & Research Clinical Haematology
Volume 22, Issue 2 , Pages 223-237, June 2009

Clinical implications of gene expression profiling in myelodysplastic syndromes: Recognition of ribosomal and translational gene dysregulation and development of predictive assays

  • Naomi Galili, PhD (Associate Professor of Medicine, New York Medical College; Director, Bone Marrow Translational Laboratory)
    • ,
  • Azra Raza, MD (Professor of Medicine, Director, MDS Program)

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +212 604 6029.

St. Vincent's Comprehensive Cancer Center, 325 West 15th Street, New York, NY 10011, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(09)00025-5

doi:10.1016/j.beha.2009.04.006

Best Practice & Research Clinical Haematology
Volume 22, Issue 2 , Pages 223-237, June 2009

Article Tools

* Image Usage & Resolution